🧠

Myasthenia Gravis Lecture Notes

Jul 13, 2024

Myasthenia Gravis: An Overview

Definition

  • Myasthenia Gravis (MG): An autoimmune condition where the body attacks muscle receptors controlling voluntary muscles, leading to muscle weakness.

Affected Muscles

  • Eyes: First signs often include drooping eyelids (ptosis) and double vision (diplopia).
  • Throat: Hoarse voice, difficulty swallowing (dysphagia), and chewing problems due to weak muscles.
  • Facial muscles: Difficulty in forming expressions.
  • Arms and legs: Muscle weakness extending to limbs.
  • Respiratory muscles: In severe cases, respiratory failure due to weak breathing muscles.

Pathophysiology

  • Neuromuscular Junction: Site where neuron meets muscle fiber.
  • Key Structures:
    • Nicotinic acetylcholine receptors: Targeted by antibodies in MG.
    • Acetylcholine: Neurotransmitter needed for muscle contraction.
    • Acetylcholine esterase: Enzyme breaking down acetylcholine.
  • Immune Response: Body produces antibodies that damage nicotinic acetylcholine receptors, reducing muscle contraction.
  • Thymus Gland: Often enlarged in MG patients, producing faulty antibodies. Located behind the sternum.

Signs and Symptoms

  • Muscle Weakness: Exacerbated by activity, improves with rest.
  • Eyelid Drooping: Ptosis, either unilateral or bilateral.
  • Expressionless Face: Due to weak facial muscles.
  • Choking/Gagging: Difficulty swallowing, risk of aspiration.
  • No Energy: Fatigue due to muscle weakness.
  • Vision Problems: Double vision (diplopia) and strabismus.
  • Slurred Speech: Hoarse or soft voice.
  • Shortness of Breath: Due to weak respiratory muscles.

Complications

  • Myasthenic Crisis: Severe muscle weakness leading to respiratory failure. Caused by under-medication, stress, or infections.
  • Cholinergic Crisis: Over-medication causing excessive acetylcholine, leading to severe muscle weakness and respiratory failure.
  • Tensilon Test: Used to differentiate between myasthenic and cholinergic crises using edrophonium.
    • Improvement indicates myasthenic crisis.
    • Worsening indicates cholinergic crisis (antidote: atropine).

Nursing Interventions

  • Respiratory Monitoring: Check effort of breathing, respiratory rate, and signs of distress.
  • Neuromuscular Assessment: Examine cranial nerves, muscle strength, vision, voice quality, and facial expressions.
  • Swallowing Evaluation: Assess risk of aspiration, consult speech pathologist, elevate head while eating.
  • Fall Prevention: Assist with walking, manage double vision and muscle weakness.
  • Patient Education: Advise on meal timings, medication schedules, and activity planning.

Treatment and Medications

  • Anticholinesterase Medications: E.g., pyridostigmine, used to increase acetylcholine availability.
    • Myasthenic Crisis: Caused by under-medication.
    • Cholinergic Crisis: Caused by over-medication.
    • Symptoms of cholinergic crisis: Pupillary constriction, bronchoconstriction, salivation, GI cramping, diarrhea, bladder incontinence, bradycardia.
  • Corticosteroids: Dampen immune response.
  • Immunosuppressants: More aggressive immune system suppression.
  • Thymectomy: Removal of thymus gland for symptom improvement.
  • Plasmapheresis/IV Immunoglobulins: Temporary removal of antibodies causing MG symptoms.

Conclusion

  • Importance of monitoring and careful management of MG symptoms for improved patient quality of life.
  • Encouragement to take the accompanying quiz and subscribe for more educational videos.